Search results for "World health"

showing 10 items of 184 documents

World Health Organization guidelines for cancer pain: a reappraisal

2005

Pain is a prevalent symptom experienced by at least 30% ofpatients undergoing an oncological treatment for metastaticdisease and by more than 70% of advanced cancer patients[1]. In 1986 the World Health Organization [2] published a setof guidelines for cancer pain management based on the three-step analgesic ladder [2]. The main aim of WHO guidelienswas to legitimize the prescribing of strong opioids, arisingfrom evidence of poor management of cancer pain, due toreluctance of health care professionals, institutions, and gov-ernment to use opioids because of fears of addition, toleranceand illegal abuse.Its application is reported to achieve satisfactory pain reliefin up to 90% of patients w…

medicine.medical_specialtyAlternative medicinePain reliefPainWorld Health OrganizationWorld healthAdrenal Cortex HormonesNeoplasmsHealth caremedicineHumansIntensive care medicineHigh rateAnalgesicsMorphinebusiness.industryBreakthrough PainSmall sampleHematologytransdermal fentanylAnalgesics OpioidOncologyOpioidAnesthesiaPractice Guidelines as TopicbusinessCancer painmedicine.drugAnnals of Oncology
researchProduct

El papel desempeñado por los programas país de la Organización Mundial de la Salud en el desarrollo de la virología en España, 1951-1975

2020

Abstract Within the framework of recent historiography about the role of the World Health Organization (WHO) in modernizing public health and the multifaceted concept of global health, this study addresses the impact of the WHO’s “country programs” in Spain from the time it was admitted to this organization in 1951 to 1975. This research adopts a transnational historical perspective and emphasizes attention to the circulation of health knowledge, practices, and people, and focuses on the Spain-0001 and Spain-0025programs, their role in the development of virology in Spain, and the transformation of public health. Sources include historical archives (WHO, the Spanish National Health School),…

medicine.medical_specialtyBiomedical ResearchEspañaMEDLINEHealth knowledgetwentieth centuryWorld Health OrganizationWorld healthvirología060104 historyHistory and Philosophy of Sciencesalud públicaPolitical scienceGlobal healthmedicineHumans0601 history and archaeologyOrganización Mundial de la Salud (OMSHistory of medicine. Medical expeditionsR131-687National healthWorld Health Organization (WHOPublic healthpublic healthHistoriography06 humanities and the artsGeneral MedicineHistory 20th CenturyVirologyvirology060105 history of science technology & medicineSpainPublic Health Practicesiglo XX
researchProduct

Oral Lichen Planus : risk factors of malignant transformation and follow up. Ten years retrospective study

2020

Background Oral Lichen Planus (OLP) is an inflammatory chronic disease. Modified World Health Organization (WHO) diagnostic criteria (2003) suggest diagnosing OLP both clinically and histologically. Furthermore, it is known the potential of malignant transformation of OLP, especially those affecting mucosa. Aims of this retrospective study on 100 patients were i) to estimate the timing of transformation of OLP lesions in OSCC in a cohort of patients observed between 2008 and 2018; ii) to assess risk factors of OLP patients diagnosed with OSCC; iii) to analyse forms of OLP evolved in cancer. Material and methods A database of 100 patients diagnosed with OLP was evaluated and clinical, histol…

medicine.medical_specialtyCancer preventionOral Medicine and Pathologybusiness.industryResearchCancerRetrospective cohort studyOdds ratiomedicine.diseaseDermatologyOral Lichen Planus Oral Cancer Malignant transformation risk factorsWorld healthMalignant transformationstomatognathic diseasesstomatognathic systemMalignant transformationCohortmedicineOral Cancerrisk factorsOral lichen planusOral Lichen PlanusbusinessGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

2020

Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment, although it is much needed for patient contracting the severe form of the disease. The aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of COVID-19. Methods PubMed, EMBASE, and three trial Registries were searched for studies on the use of chloroquine in patients with COVID-19. Results We included six articles (one narrative letter, one in-vitro study, one editorial, expert consensus paper, two national guideline documents) and 23 ongoing clinical trials in China. Chloroqui…

medicine.medical_specialtyChinaCoronaviruPneumonia ViralPsychological interventionMEDLINEDiseaseCritical Care and Intensive Care MedicineWorld Health OrganizationArticle03 medical and health sciencesAntimalarialsBetacoronavirus0302 clinical medicineChloroquinePandemicmedicineHumansIntensive care medicinePandemicsClinical Trials as Topicbusiness.industrySARS-CoV-2Public healthCOVID-19030208 emergency & critical care medicineChloroquinePneumoniaCOVID-19 Drug TreatmentClinical trialCoronavirusClinical researchTreatment Outcome030228 respiratory systembusinessCoronavirus Infectionsmedicine.drugJournal of Critical Care
researchProduct

The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria

2021

Refereed/Peer-reviewed The new IASP diagnostic criteria for complex regional pain syndrome (CRPS) (aka “the Budapest Criteria”3; Table 1) have improved the diagnostic specificity for CRPS while maintaining good sensitivity. Internationally, these criteria are now in common use. The IASP CRPS Special Interest Group convened a workshop of CRPS experts in Valencia/Spain in September 2019 to review perceived ambiguities in the diagnostic text and issues identified in applying these criteria in both the research and clinical contexts. After this review, workshop attendees discussed and reached a consensus regarding adaptations to the diagnostic taxonomy text. This process resulted in pragmatic u…

medicine.medical_specialtyConsensusMEDLINEComplex Regional Pain Syndromes/diagnosis610 Medicine & healthWorld Health OrganizationDiagnosis DifferentialPhysical medicine and rehabilitationInternational Classification of DiseasesMedicineHumansIASP diagnostic criteriaAdaptation (computer science)complex regional pain syndrome (CRPS)business.industrymedicine.diseaseAnesthesiology and Pain MedicineComplex regional pain syndrome2728 Neurology (clinical)Neurology2808 NeurologyPerspective10046 Balgrist University Hospital Swiss Spinal Cord Injury CenterNeurology (clinical)2703 Anesthesiology and Pain MedicineChronic PainbusinessComplex Regional Pain Syndromes
researchProduct

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

2020

Abstract Background and Aims Cost‐effective screening strategies are needed to make hepatitis C virus (HCV) elimination a reality. We determined if birth cohort screening is cost‐effective in Italy. Methods A model was developed to quantify screening and healthcare costs associated with HCV. The model‐estimated prevalence of undiagnosed HCV was used to calculate the antibody screens needed annually, with a €25 000 cost‐effectiveness threshold. Outcomes were assessed under the status quo and a scenario that met the World Health Organization's targets for elimination of HCV. The elimination scenario was assessed under five screening strategies. Results A graduated birth cohort screening strat…

medicine.medical_specialtyCost effectivenessCost-Benefit AnalysisHepatitis C virusSettore SECS-P/06cost-effectiveneHepacivirusmedicine.disease_causeAntiviral AgentsWorld healthNO03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansMass Screeningcost-effectivenessAntibody screensHepatologyUnder-fivebusiness.industryscreeningHealth services researchhealthcost‐effectivenessHepatitis C ChronicHepatologyHepatitis CItaly030220 oncology & carcinogenesisSettore MED/42HCVOriginal Articleepidemiology030211 gastroenterology & hepatologyLiver Disease and Public HealthQuality-Adjusted Life YearsBirth cohortbusinessWHO targetscost-effectiveness HCV screening WHO targetsDemography
researchProduct

A case report of desmoplastic ameloblastoma

2010

Ameloblastomas are the most common benign neoplasm of odontogenic nature. Desmoplastic ameloblastoma (DA) was included in the World Health Organization Classification of Head and Neck Tumors (WHO-2005) as a variant of ameloblastoma with specific clinical, image, and histological features. This case report focuses on a DA which occurred in the mandible of a 25 year-old man. The main signals and symptoms included painless swelling with buccal expansion and tooth displacement. Panoramic and periapical radiographs and cone-bean computed to- mography demonstrated an image mimicking a benign fibro-osseous lesion. The lower border of the mandible was not involved, but tooth displacement could be o…

medicine.medical_specialtyDesmoplastic ameloblastomabusiness.industryHead and neck tumorsMandibleOdontología:CIENCIAS MÉDICAS [UNESCO]Marginal resectionmedicine.diseaseCiencias de la saludWorld healthSurgeryLesionstomatognathic diseasesUNESCO::CIENCIAS MÉDICASmedicineDisplacement (orthopedic surgery)medicine.symptombusinessAmeloblastomaGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

WHO needs high FIO2?

2017

World Health Organization and the United States Center for Disease Control have recently recommended the use of 0.8 FIO2 in all adult surgical patients undergoing general anaesthesia, to prevent surgical site infections. This recommendation has arisen several discussions: As a matter of fact, there are numerous studies with different results about the effect of FIO2 on surgical site infection. Moreover, the clinical effects of FIO2 are not limited to infection control. We asked some prominent authors about their comments regarding the recent recommendations.

medicine.medical_specialtyEmergency Medicine; Anesthesiology and Pain Medicine10216 Institute of Anesthesiologybusiness.industryMEDLINE610 Medicine & health030208 emergency & critical care medicineDisease controlWorld health3. Good health03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicine030202 anesthesiologySurgical sitemedicineEmergency MedicineInfection controlGeneral anaesthesia2703 Anesthesiology and Pain Medicine2711 Emergency MedicineIntensive care medicinebusinessSurgical site infectionSurgical patients
researchProduct

COVID-19 and oral lesions, short communication and review

2021

Background The COVID-19 disease first appeared in December 2019 in Wuhan, China. The World Health Organization (WHO) declared the pandemic in March 2020, with 40 million cases and a million deaths in October 2020. COVID-19 also includes manifestations on the skin and mucous mucosal membrane. Objective: To evaluate the prevalence of the oral lesions associated to COVID-19 disease; and evaluate their clinical presentation and the hypothesized etiology. Material and methods An electronic literature search was performed in PubMed, Scopus and Indice Medico Espanol databases. The following combination of keywords and Boolean operators were used: "COVID-19 AND oral manifestations"; "COVID-19 AND o…

medicine.medical_specialtyFerides i lesionsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEReviewDiseaseWorld healthMucosa oral03 medical and health sciences0302 clinical medicineTonguemedicineGeneral DentistryUNESCO:CIENCIAS MÉDICASOral Medicine and PathologySARS-CoV-2business.industryWounds and injuriesCOVID-19030206 dentistryEvidence-based medicineDermatologymedicine.anatomical_structure030220 oncology & carcinogenesisEtiologyOral mucosabusiness
researchProduct

Association between environmental pollution and prevalence of coronavirus disease 2019 (COVID-19) in Italy

2020

AbstractThe novel coronavirus disease 2019 (COVID-19) has recently been upgraded to a pandemic by the World Health Organization due to the alarming levels of spread and severity. Since several lines of evidence also attest that Lombardy region has an extraordinarily high level of environmental pollution, we aimed to explore the potential epidemiological association between the number of cases of COVID-19 and environmental pollution in Italy. Data on environmental pollution in Italy were retrieved from the 2019 annual report of the organization Legambiente (League for the Ambient). The adjusted correlation between the number of days in which environmental pollutants exceeded established limi…

medicine.medical_specialtyGeographyCoronavirus disease 2019 (COVID-19)Environmental healthEpidemiologyPandemicmedicineEnvironmental pollutionWorld health
researchProduct